# Preemptive Co-infiltration of Triamcinolone Acetonide With Ropivacaine for Postoperative Pain in Major Spinal Surgery

> **NCT06801587** · PHASE4 · COMPLETED · sponsor: **Fang Luo** · enrollment: 118 (actual)

## Conditions studied

- Pain
- Postoperative

## Interventions

- **DRUG:** Triamcinolone acetonide plus ropivacaine
- **DRUG:** Ropivacaine alone

## Key facts

- **NCT ID:** NCT06801587
- **Lead sponsor:** Fang Luo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-05
- **Primary completion:** 2025-05-10
- **Final completion:** 2025-08-10
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06801587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06801587, "Preemptive Co-infiltration of Triamcinolone Acetonide With Ropivacaine for Postoperative Pain in Major Spinal Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06801587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*